RE: 5.15p17 May 2021 17:57
I wasn't aware of the 'negotiation' exception to rule 11 until I checked the AIM rules, but it would answer a lot of questions.
1) Hole 2 was completed about 15 weeks ago, so even with lab delays that is a long time
2) Previous RNS suggested batches for assay results, not all at once, so we should have had something by now.
3) The IP survey RNS was on schedule and we had the Eureka update too, so it isn't a problem with CBs available time.
4) This is the first time there has been a substantive RNS without an interview within a few hours. Why is he keeping quiet on the back of very positive news?
There aren't many potential scenarios:
1) The assay results are very late and CB didn't think that was worth mentioning in the RNS (seems odd)
2) The assay results are available but CB is holding on to them for anything up to several weeks in defiance of AIM rules (also seems unlikely)
3) The assay results are available but CB is in some form of negotiation and has agreed to hold off releasing for now, using the exception rule.
3) is perhaps very optimistic from a shareholder perspective, but actually makes the most sense. To quote Sherlock Holmes: When you eliminate the impossible (unlikely in this case), whatever remains, however improbable, must be the truth :)